What is the treatment for cannabis hyperemesis syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Cannabis Hyperemesis Syndrome

Definitive Treatment

Complete and permanent cessation of cannabis use is the only definitive cure for cannabis hyperemesis syndrome and must be the primary therapeutic goal. 1, 2 Symptoms resolve after abstinence for at least 6 months or a duration equal to 3 typical vomiting cycles. 1, 2


Acute Management in the Emergency Department

First-Line Pharmacologic Therapy

Haloperidol or droperidol should be prioritized as first-line agents because butyrophenones reduce hospital length of stay by nearly 50% (6.7 vs 13.9 hours, p=0.014) compared to other antiemetics. 3 These dopamine antagonists demonstrate superior efficacy over conventional antiemetics in multiple case series. 1, 4

Adjunctive Acute Therapies

  • Topical capsaicin 0.1% cream applied to the abdomen activates transient receptor potential vanilloid type 1 (TRPV1) receptors and provides symptom relief when other treatments fail. 1, 2, 5 All 13 patients in one case series experienced symptom improvement after capsaicin application. 5

  • Benzodiazepines (particularly lorazepam) are effective for acute management through sedating and anxiolytic effects that address the stress-mediated component of CHS. 3, 4 These were the most frequently reported effective treatment across case series. 4

  • Ondansetron may be tried but often demonstrates limited efficacy compared to its use in other conditions. 1, 2 Multiple studies note its suboptimal response in CHS. 4

  • Hot showers or baths provide temporary symptomatic relief and were cited as universally effective across all case reports. 4, 6 This compulsive hot water bathing behavior occurs in 44-71% of CHS patients and serves as both a diagnostic clue and temporary management strategy. 2, 3

Critical Medications to Avoid

Opioids must be avoided entirely as they worsen nausea, carry high addiction risk, and do not address the underlying pathophysiology. 1, 2, 3 Despite being mentioned in some case reports, opioids should not be considered first-line therapy. 7, 4


Long-Term Preventive Management

Pharmacologic Prevention

Tricyclic antidepressants, specifically amitriptyline, are the mainstay of long-term preventive therapy. 1, 2, 3 The dosing algorithm is:

  • Start at 25 mg at bedtime 1, 2
  • Titrate weekly by 25 mg increments 1
  • Target minimal effective dose of 75-100 mg at bedtime 1, 2
  • Monitor closely for efficacy and adverse effects 1

This recommendation comes from the 2024 American Gastroenterological Association guidelines and represents the strongest evidence for long-term management. 1

Essential Counseling

Cannabis cessation counseling is mandatory and should be initiated at every clinical encounter. 1, 2 Evidence shows that combining psychosocial interventions with pharmacology may be necessary for successful long-term management. 1 Recidivism rates are high, with many patients remaining uncertain about the role of cannabis despite recurrent episodes. 1


Diagnostic Approach Before Treatment

Rule Out Life-Threatening Conditions First

Before attributing symptoms to CHS, exclude acute abdomen, bowel obstruction, mesenteric ischemia, pancreatitis, and myocardial infarction. 1, 2, 3 CHS is frequently underdiagnosed or misdiagnosed due to limited clinician awareness. 3

Clinical Diagnostic Criteria

Suspect CHS when all three criteria are met: 1, 2

  1. Clinical features: Stereotypical episodic vomiting with acute onset, occurring ≥3 times annually 1, 2

  2. Cannabis use patterns: Duration >1 year before symptom onset, frequency >4 times per week on average 1, 2

  3. Cannabis cessation: Resolution of symptoms after abstinence for ≥6 months or duration equal to 3 typical vomiting cycles 1, 2

Key Diagnostic Clue

Compulsive hot water bathing behavior (prolonged hot baths or showers for symptom relief) occurs in 71-92% of CHS patients and strongly suggests the diagnosis. 1, 2 While not pathognomonic (also seen in cyclic vomiting syndrome), it is a highly characteristic feature. 1


Common Pitfalls to Avoid

  • Do not rely on switching to lower THC/higher CBD formulations or edible forms as these strategies lack scientific validation. 1 Edibles deliver THC systemically just as effectively as smoking, and total THC dose—not delivery method—is the critical factor. 3

  • Do not underestimate recidivism risk. Despite diagnosis and counseling, many patients continue cannabis use and characterize symptoms as food-related rather than cannabis-related. 1

  • Do not use conventional antiemetic protocols. The American Gastroenterological Association and British Journal of Anaesthesia recommend multimodal antiemetic prophylaxis that differs from standard postoperative nausea and vomiting protocols. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Cannabis Hyperemesis Syndrome (CHS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cannabinoid Hyperemesis Syndrome Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2017

Research

Managing cannabinoid hyperemesis syndrome in adult patients in the emergency department.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.